Donna Skerrett

Dose of Prophylactic Platelet Transfusions and Prevention of Hemorrhage

Sherrill J. Slichter, Richard M. Kaufman, Susan F. Assmann et al. · New England Journal of Medicine · 2010 · 663 citations · Full text

Medicine, Hematology, Internal Medicine +16

A Phase II Dose-Escalation Study of Allogeneic Mesenchymal Precursor Cells in Patients With Ischemic or Nonischemic Heart Failure

Emerson C. Perin, Kenneth M. Borow, Guilherme V. Silva et al. · Circulation Research · 2015 · 204 citations · Full text

Medicine, Cardiology, Immunology +14

A Phase 3 Randomized Study of Remestemcel-L versus Placebo Added to Second-Line Therapy in Patients with Steroid-Refractory Acute Graft-versus-Host Disease

Partow Kebriaei, Jack Hayes, Andrew Daly et al. · Biology of Blood and Marrow Transplantation · 2019 · 201 citations · Full text

Pharmacy, Immunology, Cell Therapy +12

A Phase 3, Single-Arm, Prospective Study of Remestemcel-L, Ex Vivo Culture-Expanded Adult Human Mesenchymal Stromal Cells for the Treatment of Pediatric Patients Who Failed to Respond to Steroid Treatment for Acute Graft-versus-Host Disease

Joanne Kurtzberg, Hisham Abdel‐Azim, Paul A. Carpenter et al. · Biology of Blood and Marrow Transplantation · 2020 · 195 citations · Full text

Medicine, Hematology, Pediatrics +17

Mesenchymal Precursor Cells as Adjunctive Therapy in Recipients of Contemporary Left Ventricular Assist Devices

Deborah D. Ascheim, Annetine C. Gelijns, Daniel J. Goldstein et al. · Circulation · 2014 · 174 citations · Full text

Medicine, Cardiology, Immunology +17